Contraline, Inc. — Form D
Contraline, Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-05. The offering totals $7.5M, of which $7.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-04-05
- Form: D
- Accession: 0001818752-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.2M
- Remaining: $274K
- Investors: 22
- Date of first sale: 2021-03-02
- Revenue range: Decline to Disclose
- SEC file number: 021-440487
Issuer
- Name: Contraline, Inc.
- CIK: 0001818752
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 818 E. Jefferson St Suite 201, CHARLOTTESVILLE, VA, 22902
- Phone: (347) 327-3676
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Gurdane Bhutani | Director | Claymont, DE |
| Kevin Eisenfrats | Director | Charlottesville, VA |
| Martin Emerson | Director | Minnetonka, MN |
| Michael King | Director | ROAD TOWN, TORTOLA, D8 |
| Tom Thorpe | Director | Charlottesville, VA |
| Kevin Eisenfrats | Executive Officer | Charlottesville, VA |
| Kevin Eisenfrats | Promoter | Charlottesville, VA |
| Gurdane Bhutani | Related Person | Claymont, DE |
| Martin J Emerson | Related Person | CHARLOTTESVILLE, VA |
| Kevin S Eisenfrats | Related Person | CHARLOTTESVILLE, VA |
| Iris Van Alderwerelt van Rosenburgh | Related Person | CHARLOTTESVILLE, VA |
Other filings by this issuer (1)
More